Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital

Germline whole genome sequencing in pediatric oncology in Denmark-Practitioner perspectives

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Exome data clouds the pathogenicity of genetic variants in Pulmonary Arterial Hypertension

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Dentinogenesis imperfecta type II- genotype and phenotype analyses in three Danish families

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Analyses of more than 60,000 exomes questions the role of numerous genes previously associated with dilated cardiomyopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Genomforskningsprojekt påviser TP53-mutation hos en pige med rabdomyosarkom

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Genetic predisposition to childhood cancer – a nationwide whole genome sequencing study

    Publikation: Bog/antologi/afhandling/rapportPh.d.-afhandling

  4. A shared somatic translocation involving CUX1 in monozygotic twins as an early driver of AMKL in Down syndrome

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

Vis graf over relationer

BACKGROUND: With the implementation of a research project providing whole genome sequencing (WGS) to all pediatric cancer patients in Denmark (2016-2019), we sought to investigate healthcare professionals' views on WGS as it was actively being implemented in pediatric oncology.

METHODS: Semistructured interviews were carried out with pediatric oncologists, clinical geneticists, and research coordinating nurses (N = 17), followed by content analysis of transcribed interviews. Interviews were supplemented by ethnographic observations on Danish pediatric oncology wards. Additionally, questionnaires were distributed to healthcare professionals concerning when they found it appropriate to approach families regarding WGS. The response rate was 74%.

RESULTS: Healthcare professionals see imbalances in doctor-patient relationship, especially the double role doctors have as clinicians and researchers. Some were concerned that it might not be possible to obtain meaningful informed consent from all families following diagnosis. Still, 94% of respondents found it acceptable to approach families during the first 4 weeks from the child's diagnosis. Views on the utility of WGS, treatment adaptation, and surveillance differed among interviewees.

CONCLUSION: Overall, healthcare professionals see dilemmas arising from WGS in the pediatric oncology clinic, and some advocate for further educational sessions with families and healthcare professionals. Despite concerns, healthcare professionals overwhelmingly supported early approach of families regarding WGS. Interviewees disagree on the benefits of surveillance based on genetic findings.

TidsskriftMolecular Genetics & Genomic Medicine
Udgave nummer8
Sider (fra-til)e1276
StatusUdgivet - aug. 2020

Bibliografisk note

© 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.

ID: 61714315